319 related articles for article (PubMed ID: 11702815)
1. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
2. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for statin-associated rhabdomyolysis.
Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
[TBL] [Abstract][Full Text] [Related]
6. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Jones PH; Davidson MH
Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
[TBL] [Abstract][Full Text] [Related]
7. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
8. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
9. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
SantaCruz PL; González A; León ME; Fernández MY
Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
[No Abstract] [Full Text] [Related]
10. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
Landesman KA; Stozek M; Freeman NJ
Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
Marsà Carretero M; Alos Manrique C; Valles Callol JA
Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
[No Abstract] [Full Text] [Related]
12. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
[TBL] [Abstract][Full Text] [Related]
14. Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations.
Kar S; Chockalingam A
Am J Ther; 2013 Jan; 20(1):57-60. PubMed ID: 21192242
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
[TBL] [Abstract][Full Text] [Related]
16. A lesson for everyone in drug-drug interactions.
Akram K; Rao S; Parker M
Int J Cardiol; 2007 May; 118(1):e19-20. PubMed ID: 17368833
[TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyolysis and cholestatic hepatitis under treatment with simvastatin and chlorzoxazone].
Bielecki JW; Schraner C; Briner V; Kuhn M
Schweiz Med Wochenschr; 1999 Apr; 129(13):514-8. PubMed ID: 10322565
[TBL] [Abstract][Full Text] [Related]
18. Concomitant administration of simvastatin and danazol associated with fatal rhabdomyolysis.
Stankovic I; Vlahovic-Stipac A; Putnikovic B; Cvetkovic Z; Neskovic AN
Clin Ther; 2010 May; 32(5):909-14. PubMed ID: 20685498
[TBL] [Abstract][Full Text] [Related]
19. Bayer pulls cerivastatin (Baycol) from market.
Wooltorton E
CMAJ; 2001 Sep; 165(5):632. PubMed ID: 11563216
[No Abstract] [Full Text] [Related]
20. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
Gumprecht J; Zychma M; Grzeszczak W; Kuźniewicz R; Burak W; Zywiec J; Karasek D; Otulski I; Mosur M
Med Sci Monit; 2003 Sep; 9(9):CS89-91. PubMed ID: 12960932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]